2888-09-7 Usage
General Description
Methyl 2-hydroxy-5-methoxy-3-nitrobenzoate 95+%, also known as methyl anthranilate, is a chemical compound commonly used in the production of perfumes and flavoring agents. It is a clear, pale yellow liquid with a strong sweet, floral, and fruity odor, which makes it a popular ingredient in various fragrance formulations. The compound is typically obtained through the esterification of anthranilic acid with methanol. It is also used as an insect repellent and in the production of sunscreens and pharmaceuticals. Additionally, it has applications in the food industry as a flavoring agent, particularly in the production of grape and orange flavors. Methyl 2-hydroxy-5-methoxy-3-nitrobenzoate 95+% is considered to be of high purity, making it suitable for use in a wide range of industrial and commercial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 2888-09-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,8 and 8 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2888-09:
(6*2)+(5*8)+(4*8)+(3*8)+(2*0)+(1*9)=117
117 % 10 = 7
So 2888-09-7 is a valid CAS Registry Number.
2888-09-7Relevant articles and documents
An improved high yield total synthesis and cytotoxicity study of the marine alkaloid neoamphimedine: An ATP-competitive inhibitor of topoisomerase IIα and potent anticancer agent
Li, Linfeng,Abraham, Adedoyin D.,Zhou, Qiong,Ali, Hadi,O'Brien, Jeremy V.,Hamill, Brayden D.,Arcaroli, John J.,Messersmith, Wells A.,LaBarbera, Daniel V.
, p. 4833 - 4850 (2015/01/08)
Recently, we characterized neoamphimedine (neo) as an ATP-competitive inhibitor of the ATPase domain of human Topoisomerase IIα. Thus far, neo is the only pyridoacridine with this mechanism of action. One limiting factor in the development of neo as a the
CETP INHIBITORS
-
Page/Page column 135, (2008/06/13)
Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. I
